Response to the letter 'testing the effectiveness of MyPROSLE in classifying patients with lupus nephritis'

Brief Bioinform. 2023 Nov 22;25(1):bbad454. doi: 10.1093/bib/bbad454.

¹ GENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.
² Fundación para la Investigación Biosanitaria de Andalucía Oriental-Alejandro Otero (FIBAO), 18012, Granada, Spain.
³ Department of Statistics, University of Granada, 18071, Granada, Spain.
⁴ Johns Hopkins University School of Medicine, Baltimore, Maryland.
⁵ Unit of Inflammatory Diseases, Department of Environmental Medicine, Karolinska Institute, 171 67, Solna, Sweden.

No abstract available

Keywords: autoimmunity; machine learning; omics data; personalized medicine; systemic lupus erythematosus; transcriptomics.

Publication types